List of Tables
Table 1. Immuno-oncology Drugs Market Trends
Table 2. Immuno-oncology Drugs Market Drivers & Opportunity
Table 3. Immuno-oncology Drugs Market Challenges
Table 4. Immuno-oncology Drugs Market Restraints
Table 5. Global Immuno-oncology Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Immuno-oncology Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Immuno-oncology Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Immuno-oncology Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Immuno-oncology Drugs
Table 10. Global Immuno-oncology Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Immuno-oncology Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Immuno-oncology Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Immuno-oncology Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Immuno-oncology Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Immuno-oncology Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Immuno-oncology Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Immuno-oncology Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Immuno-oncology Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Immuno-oncology Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Immuno-oncology Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Immuno-oncology Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Immuno-oncology Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Immuno-oncology Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Immuno-oncology Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Immuno-oncology Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Immuno-oncology Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Immuno-oncology Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Immuno-oncology Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Amgen, Inc Basic Information List
Table 32. Amgen, Inc Description and Business Overview
Table 33. Amgen, Inc Immuno-oncology Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Immuno-oncology Drugs Business of Amgen, Inc (2019-2024)
Table 35. Amgen, Inc Recent Developments
Table 36. AstraZeneca, Plc Basic Information List
Table 37. AstraZeneca, Plc Description and Business Overview
Table 38. AstraZeneca, Plc Immuno-oncology Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Immuno-oncology Drugs Business of AstraZeneca, Plc (2019-2024)
Table 40. AstraZeneca, Plc Recent Developments
Table 41. Bristol-Myers Squibb Basic Information List
Table 42. Bristol-Myers Squibb Description and Business Overview
Table 43. Bristol-Myers Squibb Immuno-oncology Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Immuno-oncology Drugs Business of Bristol-Myers Squibb (2019-2024)
Table 45. Bristol-Myers Squibb Recent Developments
Table 46. Celgene Corporation Basic Information List
Table 47. Celgene Corporation Description and Business Overview
Table 48. Celgene Corporation Immuno-oncology Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Immuno-oncology Drugs Business of Celgene Corporation (2019-2024)
Table 50. Celgene Corporation Recent Developments
Table 51. Eli Lilly and Company Basic Information List
Table 52. Eli Lilly and Company Description and Business Overview
Table 53. Eli Lilly and Company Immuno-oncology Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Immuno-oncology Drugs Business of Eli Lilly and Company (2019-2024)
Table 55. Eli Lilly and Company Recent Developments
Table 56. Merck & Co. Basic Information List
Table 57. Merck & Co. Description and Business Overview
Table 58. Merck & Co. Immuno-oncology Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Immuno-oncology Drugs Business of Merck & Co. (2019-2024)
Table 60. Merck & Co. Recent Developments
Table 61. Hoffmann-La Roche AG Basic Information List
Table 62. Hoffmann-La Roche AG Description and Business Overview
Table 63. Hoffmann-La Roche AG Immuno-oncology Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Immuno-oncology Drugs Business of Hoffmann-La Roche AG (2019-2024)
Table 65. Hoffmann-La Roche AG Recent Developments
Table 66. Johnson & Johnson Basic Information List
Table 67. Johnson & Johnson Description and Business Overview
Table 68. Johnson & Johnson Immuno-oncology Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Immuno-oncology Drugs Business of Johnson & Johnson (2019-2024)
Table 70. Johnson & Johnson Recent Developments
Table 71. Novartis International AG Basic Information List
Table 72. Novartis International AG Description and Business Overview
Table 73. Novartis International AG Immuno-oncology Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Immuno-oncology Drugs Business of Novartis International AG (2019-2024)
Table 75. Novartis International AG Recent Developments
Table 76. AbbVie, Inc. Basic Information List
Table 77. AbbVie, Inc. Description and Business Overview
Table 78. AbbVie, Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Immuno-oncology Drugs Business of AbbVie, Inc. (2019-2024)
Table 80. AbbVie, Inc. Recent Developments
Table 81. Pfizer Inc. Basic Information List
Table 82. Pfizer Inc. Description and Business Overview
Table 83. Pfizer Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Immuno-oncology Drugs Business of Pfizer Inc. (2019-2024)
Table 85. Pfizer Inc. Recent Developments
Table 86. Sanofi S.A. Basic Information List
Table 87. Sanofi S.A. Description and Business Overview
Table 88. Sanofi S.A. Immuno-oncology Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Immuno-oncology Drugs Business of Sanofi S.A. (2019-2024)
Table 90. Sanofi S.A. Recent Developments
Table 91. EMD Serono, Inc. Basic Information List
Table 92. EMD Serono, Inc. Description and Business Overview
Table 93. EMD Serono, Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Immuno-oncology Drugs Business of EMD Serono, Inc. (2019-2024)
Table 95. EMD Serono, Inc. Recent Developments
Table 96. Gilead Sciences Inc. Basic Information List
Table 97. Gilead Sciences Inc. Description and Business Overview
Table 98. Gilead Sciences Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Immuno-oncology Drugs Business of Gilead Sciences Inc. (2019-2024)
Table 100. Gilead Sciences Inc. Recent Developments
Table 101. Prometheus Therapeutics & Diagnostics Basic Information List
Table 102. Prometheus Therapeutics & Diagnostics Description and Business Overview
Table 103. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Immuno-oncology Drugs Business of Prometheus Therapeutics & Diagnostics (2019-2024)
Table 105. Prometheus Therapeutics & Diagnostics Recent Developments
Table 106. Aduro BioTech Basic Information List
Table 107. Aduro BioTech Description and Business Overview
Table 108. Aduro BioTech Immuno-oncology Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Immuno-oncology Drugs Business of Aduro BioTech (2019-2024)
Table 110. Aduro BioTech Recent Developments
Table 111. Galena Biopharma Basic Information List
Table 112. Galena Biopharma Description and Business Overview
Table 113. Galena Biopharma Immuno-oncology Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Immuno-oncology Drugs Business of Galena Biopharma (2019-2024)
Table 115. Galena Biopharma Recent Developments
Table 116. Bavarian Nordic Basic Information List
Table 117. Bavarian Nordic Description and Business Overview
Table 118. Bavarian Nordic Immuno-oncology Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Immuno-oncology Drugs Business of Bavarian Nordic (2019-2024)
Table 120. Bavarian Nordic Recent Developments
Table 121. Celldex Therapeutics Basic Information List
Table 122. Celldex Therapeutics Description and Business Overview
Table 123. Celldex Therapeutics Immuno-oncology Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Immuno-oncology Drugs Business of Celldex Therapeutics (2019-2024)
Table 125. Celldex Therapeutics Recent Developments
Table 126. ImmunoCellular Therapeutics Basic Information List
Table 127. ImmunoCellular Therapeutics Description and Business Overview
Table 128. ImmunoCellular Therapeutics Immuno-oncology Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Immuno-oncology Drugs Business of ImmunoCellular Therapeutics (2019-2024)
Table 130. ImmunoCellular Therapeutics Recent Developments
Table 131. Incyte Basic Information List
Table 132. Incyte Description and Business Overview
Table 133. Incyte Immuno-oncology Drugs Products, Services and Solutions
Table 134. Revenue (US$ Million) in Immuno-oncology Drugs Business of Incyte (2019-2024)
Table 135. Incyte Recent Developments
Table 136. Dendreon Corporation Basic Information List
Table 137. Dendreon Corporation Description and Business Overview
Table 138. Dendreon Corporation Immuno-oncology Drugs Products, Services and Solutions
Table 139. Revenue (US$ Million) in Immuno-oncology Drugs Business of Dendreon Corporation (2019-2024)
Table 140. Dendreon Corporation Recent Developments
Table 141. Agilent Technologies Inc. Basic Information List
Table 142. Agilent Technologies Inc. Description and Business Overview
Table 143. Agilent Technologies Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 144. Revenue (US$ Million) in Immuno-oncology Drugs Business of Agilent Technologies Inc. (2019-2024)
Table 145. Agilent Technologies Inc. Recent Developments
Table 146. Agenus Inc. Basic Information List
Table 147. Agenus Inc. Description and Business Overview
Table 148. Agenus Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 149. Revenue (US$ Million) in Immuno-oncology Drugs Business of Agenus Inc. (2019-2024)
Table 150. Agenus Inc. Recent Developments
Table 151. Enzo Biochem, Inc. Basic Information List
Table 152. Enzo Biochem, Inc. Description and Business Overview
Table 153. Enzo Biochem, Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 154. Revenue (US$ Million) in Immuno-oncology Drugs Business of Enzo Biochem, Inc. (2019-2024)
Table 155. Enzo Biochem, Inc. Recent Developments
Table 156. Lonza Group Basic Information List
Table 157. Lonza Group Description and Business Overview
Table 158. Lonza Group Immuno-oncology Drugs Products, Services and Solutions
Table 159. Revenue (US$ Million) in Immuno-oncology Drugs Business of Lonza Group (2019-2024)
Table 160. Lonza Group Recent Developments
Table 161. Bio-Rad Laboratories, Inc. Basic Information List
Table 162. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 163. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 164. Revenue (US$ Million) in Immuno-oncology Drugs Business of Bio-Rad Laboratories, Inc. (2019-2024)
Table 165. Bio-Rad Laboratories, Inc. Recent Developments
Table 166. Avantor, Inc. Basic Information List
Table 167. Avantor, Inc. Description and Business Overview
Table 168. Avantor, Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 169. Revenue (US$ Million) in Immuno-oncology Drugs Business of Avantor, Inc. (2019-2024)
Table 170. Avantor, Inc. Recent Developments
Table 171. Spring Bank Pharmaceuticals, Inc. Basic Information List
Table 172. Spring Bank Pharmaceuticals, Inc. Description and Business Overview
Table 173. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Products, Services and Solutions
Table 174. Revenue (US$ Million) in Immuno-oncology Drugs Business of Spring Bank Pharmaceuticals, Inc. (2019-2024)
Table 175. Spring Bank Pharmaceuticals, Inc. Recent Developments
Table 176. Ferring Pharmaceuticals Basic Information List
Table 177. Ferring Pharmaceuticals Description and Business Overview
Table 178. Ferring Pharmaceuticals Immuno-oncology Drugs Products, Services and Solutions
Table 179. Revenue (US$ Million) in Immuno-oncology Drugs Business of Ferring Pharmaceuticals (2019-2024)
Table 180. Ferring Pharmaceuticals Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Immuno-oncology Drugs Downstream Customers
Table 184. Immuno-oncology Drugs Distributors List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
Table 188. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Immuno-oncology Drugs Product Picture
Figure 2. Global Immuno-oncology Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Immuno-oncology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Immuno-oncology Drugs Report Years Considered
Figure 5. Global Immuno-oncology Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Immuno-oncology Drugs Revenue in 2023
Figure 7. Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immune Checkpoint Inhibitors Picture
Figure 9. Immune System Modulators Picture
Figure 10. Cancer Vaccines Picture
Figure 11. Oncolytic Virus Picture
Figure 12. Others Picture
Figure 13. Global Immuno-oncology Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Immuno-oncology Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Clinics
Figure 17. Product Picture of Ambulatory Surgical Centers
Figure 18. Global Immuno-oncology Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Immuno-oncology Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Immuno-oncology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Immuno-oncology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Immuno-oncology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Immuno-oncology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Immuno-oncology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Immuno-oncology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Immuno-oncology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Immuno-oncology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Immuno-oncology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Immuno-oncology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Immuno-oncology Drugs Sales Value (%), (2019-2030)
Figure 31. United States Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 37. China Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. China Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. India Immuno-oncology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Immuno-oncology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. India Immuno-oncology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Immuno-oncology Drugs Industrial Chain
Figure 53. Immuno-oncology Drugs Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
